A detailed history of Clearstead Advisors, LLC transactions in Genmab A/S stock. As of the latest transaction made, Clearstead Advisors, LLC holds 1,659 shares of GMAB stock, worth $33,959. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,659
Previous 1,902 12.78%
Holding current value
$33,959
Previous $47,000 14.89%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$23.84 - $28.48 $5,793 - $6,920
-243 Reduced 12.78%
1,659 $40,000
Q2 2024

Aug 09, 2024

BUY
$25.13 - $30.27 $39,906 - $48,068
1,588 Added 505.73%
1,902 $47,000
Q1 2024

May 14, 2024

SELL
$26.43 - $32.77 $2,405 - $2,982
-91 Reduced 22.47%
314 $9,000
Q4 2023

Feb 12, 2024

BUY
$27.94 - $35.44 $5,588 - $7,088
200 Added 97.56%
405 $12,000
Q3 2023

Nov 07, 2023

BUY
$35.27 - $42.24 $7,230 - $8,659
205 New
205 $7,000
Q4 2021

Feb 14, 2022

SELL
$35.87 - $47.12 $67,794 - $89,056
-1,890 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$41.55 - $48.72 $78,529 - $92,080
1,890 New
1,890 $83,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.5B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.